-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Amgen, Raises Price Target to $465

Benzinga·11/04/2026 20:58:53
Listen to the news
Citigroup analyst Geoff Meacham maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $405 to $465.